ArticleFrontiers in medicine2025
A patient journey mapping study of lived experiences during platelet-rich fibrin gel therapy for venous leg ulcers.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of platelet-rich fibrin gel combined with alginate dressing on healing of active venous leg ulcers: a randomized clinical trial.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Active venous leg ulcers (VLUs), characterized by high recurrence and complexity of treatment, place patients under a dual physiological and psychological stress. Platelet-rich fibrin (PRF) shows biological therapeutic potential, but current research predominantly focuses on its clinical efficacy through quantitative measures such as wound healing rates, leaving a significant gap in understanding the holistic therapeutic experience and multidimensional psychological-cognitive journey of patients undergoing this novel treatment. This gap limits the development of patient-centered care strategies that could optimize both biological and psychosocial outcomes. Objective and methods: This study aimed to identify key stages and touchpoints where patient needs, distress, and decision-making are most pronounced during PRF gel therapy, by employing patient journey mapping to visualize and analyze the holistic treatment experience. A descriptive phenomenology study using semi-structured interviews was conducted in 13 active VLU patients from June to December 2024. The data were analyzed using the seven-step Colaizzi method to identify themes and to construct a dynamic journey model that integrates cognition, experience, and emotions. Results: The analysis revealed four core themes: pre-treatment cognitive dissonance and hope; treatment-phase challenges; post-treatment biopsychosocial shifts; and dynamic anxiety-hope oscillation. Conclusion: Patients reported that PRF gel therapy, within the context of comprehensive wound care, was associated with enhanced wound healing and improved psychological wellbeing. The proposed patient journey map translates these lived experiences into a structured framework, offering actionable insights for implementing patient-centered care and optimizing management strategies for refractory VLUs. Implications: Clinically, this framework aids in identifying high-need phases of the treatment journey and provides a basis for tailoring patient education and support, ultimately helping to improve both clinical workflows and patient engagement in PRF-based wound management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.